PanGen Biotech Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	2,051	943.69	-4,489	-4,494	-3,310
Depreciation & Amortization	1,465	1,468	1,597	1,603	1,532
Loss (Gain) From Sale of Assets	-17.01	-13.94	-15.15	0.24	0.67
Stock-Based Compensation	-	-	12.18	236.78	224.6
Provision & Write-off of Bad Debts	-252.64	148.57	148.57	-	-
Other Operating Activities	-78.92	658.72	1,052	642.78	693.36
Change in Accounts Receivable	1,646	-746.76	-1,659	386.46	-552.25
Change in Inventory	-1,228	930.24	-752.12	-2,257	-608.69
Change in Accounts Payable	-265.49	124.51	43.34	-126.43	85.41
Change in Other Net Operating Assets	-3,130	-526.46	612.11	505.41	-1,389
Operating Cash Flow	189.81	2,987	-3,451	-3,503	-3,324
Operating Cash Flow Growth	-93.64%	-	-	-	-
Capital Expenditures	-562.81	-360.06	-422.13	-728.05	-1,425
Sale of Property, Plant & Equipment	17.09	150	15.2	34.62	-
Sale (Purchase) of Intangibles	-174.61	-14.07	-62.86	-5.8	-49.29
Investment in Securities	250.3	-10,077	-50	15,048	-4,451
Other Investing Activities	-342.16	-35.8	-51.34	-119.4	-100.22
Investing Cash Flow	-812.18	-10,337	-571.13	14,229	-6,026
Short-Term Debt Issued	-	980	986	-	-
Long-Term Debt Issued	-	-	3,204	60.19	68.91
Total Debt Issued	-	980	4,190	60.19	68.91
Short-Term Debt Repaid	-	-980	-986	-	-
Long-Term Debt Repaid	-1.84	-516.88	-1.56	-18,829	-1.04
Total Debt Repaid	-1.84	-1,497	-987.56	-18,829	-1.04
Net Debt Issued (Repaid)	-1.84	-516.88	3,202	-18,769	67.88
Issuance of Common Stock	2,967	9,261	-	33.68	10,051
Other Financing Activities	-2.69	-9.43	-27.34	-0.51	-6.16
Financing Cash Flow	2,963	8,735	3,175	-18,736	10,112
Foreign Exchange Rate Adjustments	-14.86	-	-	-	-
Miscellaneous Cash Flow Adjustments	-	-	-	-0	-0
Net Cash Flow	2,326	1,385	-847.06	-8,009	762.18
Free Cash Flow	-373	2,627	-3,873	-4,231	-4,749
Free Cash Flow Margin	-2.78%	17.90%	-52.94%	-65.08%	-59.85%
Free Cash Flow Per Share	-26.56	228.26	-362.70	-396.34	-464.83
Cash Interest Paid	0.12	1.15	2.29	0.53	0.53
Cash Income Tax Paid	60.91	69.84	-39.51	79.39	34.79
Levered Free Cash Flow	1,280	228.45	-1,012	-2,828	-4,331
Unlevered Free Cash Flow	1,372	429.76	-874.1	-2,748	-4,148
Change in Working Capital	-2,978	-218.46	-1,756	-1,492	-2,464

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.